Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIBROTHERME: Spa Care for Late Fibrosis After Radiotherapy for Breast Cancer
NCT02898376Phase 3Unknown
- Sponsor
- Institut de Cancérologie de Lorraine
- Start
- Dec 2018
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in breast cancer and radiation-induced fibrosis (RIF) (2 arms), sponsored by Institut de Cancérologie de Lorraine. Primary endpoint: Dermatology Quality of life at 6 months. Status: unknown.
02
Conditions
breast cancerradiation-induced fibrosis (RIF)
Beyond the preview
Go deeper on NCT02898376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02898376.